Suchergebnisse - "Tamai, Yasuyuki"

PubPharm (41)

1

Effectiveness of 1-year pemafibrate treatment on steatotic liver disease : the influence of alcohol consumption

enthalten in: European journal of gastroenterology & hepatology | 2024

von Iwasa, M. | Sugimoto, R. | Eguchi, A. | +8

2

Serum Zinc-α2-glycoprotein Levels Are Associated with the Hepatorenal Function and Predict the Survival in Cases of Chronic Liver Disease

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Shigefuku, R. | Iwasa, M. | Eguchi, A. | +8

3

Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma

enthalten in: Cancers | 2023

von Tamai, Y. | Fujiwara, N. | Tanaka, T. | +2

4

Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Saeki, I. | Suehiro, Y. | Yamauchi, Y. | +16

CommentIn: Hepatol Int. 2023 Apr;17(2):279-280. - PMID 37000388

5

Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab

enthalten in: Internal medicine (Tokyo, Japan) | 2023

von Shigefuku, R. | Yoshikawa, K. | Tsukimoto, M. | +11

6

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients

enthalten in: Frontiers in medicine | 2023

von Sugimoto, R. | Iwasa, M. | Eguchi, A. | +8

7

The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment

enthalten in: European journal of gastroenterology & hepatology | 2022

von Tamai, Y. | Iwasa, M. | Eguchi, A. | +6

8

Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans

enthalten in: eLife | 2022

von Tamai, Y. | Eguchi, A. | Shigefuku, R. | +7

9

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis

enthalten in: Hepatology communications | 2022

von Eguchi, A. | Iwasa, M. | Yamada, M. | +15

10

Serum copeptin and zinc-α2-glycoprotein levels are novel biomarkers of tolvaptan treatment in decompensated cirrhotic patients with ascites.

enthalten in: ResearchSquare.com | 2022

von Shigefuku, R. | Iwasa, M. | Eguchi, A. | +4

1
2
3
4
5
Nächster »
[5]